Identifikation und immunologische Charakterisierung von MHC ...

6. Literaturverzeichnis
Steinman, RM and Nussenzweig, MC (2002). Avoiding horror autotoxicus: the
importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad.
Sci. U S A 99(1): 351-358.
Steinman, RM (2003). The control of immunity and tolerance by dendritic cell.
Pathol. Biol. (Paris) 51(2): 59-60.
Steitz, J., Bruck, J., Lenz, J., Knop, J. and Tuting, T. (2001). Depletion of CD25(+)
CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced
dendritic cells enhance the interferon alpha-induced, CD8(+) T-celldependent
immune defense of B16 melanoma. Cancer Res. 61(24): 8643-8646.
Sturniolo, T., Bono, E., Ding, J., Raddrizzani, L., Tuereci, O., Sahin, U.,
Braxenthaler, M., Gallazzi, F., Protti, MP, Sinigaglia, F. and Hammer, J. (1999).
Generation of tissue-specific and promiscuous HLA ligand databases using
DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol. 17: 555-
561.
Sutmuller, RP, van Duivenvoorde, LM, van Elsas, A., Schumacher, TN,
Wildenberg, ME, Allison, JP, Toes, RE, Offringa, R. and Melief, CJ (2001).
Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and
depletion of CD25(+) regulatory T cells in antitumor therapy reveals
alternative pathways for suppression of autoreactive cytotoxic T lymphocyte
responses. J. Exp. Med. 194(6): 823-832.
Swana, HS, Grossman, D., Anthony, JN, Weiss, RM and Altieri, DC (1999).
Tumor content of the antiapoptosis molecule survivin and recurrence of
bladder cancer. N. Engl. J. Med. 341: 452-453.
Tamm, I., Wang, Y., Sausville, E., Scudiero, DA, Vigna, N., Oltersdorf, T. and
Reed, JC (1998). IAP-family protein survivin inhibits caspase activity and
121